367 related articles for article (PubMed ID: 34983390)
1. Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies.
Tu H; Zhang ZW; Qiu L; Lin Y; Jiang M; Chia SY; Wei Y; Ng ASL; Reynolds R; Tan EK; Zeng L
BMC Neurosci; 2022 Jan; 23(1):3. PubMed ID: 34983390
[TBL] [Abstract][Full Text] [Related]
2. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
Jellinger KA
J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
[TBL] [Abstract][Full Text] [Related]
3. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
Jellinger KA; Korczyn AD
BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease.
Walker L; Simpson H; Thomas AJ; Attems J
Acta Neuropathol Commun; 2024 Feb; 12(1):28. PubMed ID: 38360761
[TBL] [Abstract][Full Text] [Related]
5. Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson's disease dementia.
Frigerio I; Laansma MA; Lin CP; Hermans EJM; Bouwman MMA; Bol JGJM; Galis-de Graaf Y; Hepp DH; Rozemuller AJM; Barkhof F; van de Berg WDJ; Jonkman LE
Transl Neurodegener; 2023 Jan; 12(1):3. PubMed ID: 36658627
[TBL] [Abstract][Full Text] [Related]
6. [Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].
Bencs V; Bencze J; Módis VL; Simon V; Kálmán J; Hortobágyi T
Orv Hetil; 2020 May; 161(18):727-737. PubMed ID: 32338488
[TBL] [Abstract][Full Text] [Related]
7. Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?
Jellinger KA
Parkinsonism Relat Disord; 2022 Jul; 100():24-32. PubMed ID: 35691178
[TBL] [Abstract][Full Text] [Related]
8. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
[TBL] [Abstract][Full Text] [Related]
9. Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.
Hansen D; Ling H; Lashley T; Foley JA; Strand C; Eid TM; Holton JL; Warner TT
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):143-156. PubMed ID: 32720329
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Rolinski M; Fox C; Maidment I; McShane R
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
[TBL] [Abstract][Full Text] [Related]
11. Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia.
Jellinger KA
J Neural Transm (Vienna); 2023 Jul; 130(7):891-904. PubMed ID: 37306790
[TBL] [Abstract][Full Text] [Related]
12. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
Beyer MK; Larsen JP; Aarsland D
Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
[TBL] [Abstract][Full Text] [Related]
13. Nigral Pathology Contributes to Microstructural Integrity of Striatal and Frontal Tracts in Parkinson's Disease.
Lin CP; Knoop LEJ; Frigerio I; Bol JGJM; Rozemuller AJM; Berendse HW; Pouwels PJW; van de Berg WDJ; Jonkman LE
Mov Disord; 2023 Sep; 38(9):1655-1667. PubMed ID: 37347552
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P
Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.
Borroni B; Premi E; Formenti A; Turrone R; Alberici A; Cottini E; Rizzetti C; Gasparotti R; Padovani A
Parkinsonism Relat Disord; 2015 Sep; 21(9):1049-55. PubMed ID: 26109553
[TBL] [Abstract][Full Text] [Related]
16. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
Tsuboi Y; Dickson DW
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
[TBL] [Abstract][Full Text] [Related]
17. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
[TBL] [Abstract][Full Text] [Related]
18. Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease.
Iseki E
Neuropathology; 2004 Mar; 24(1):72-8. PubMed ID: 15068176
[TBL] [Abstract][Full Text] [Related]
19. Locus Coeruleus Pathology Indicates a Continuum of Lewy Body Dementia.
Tilley BS; Patel SR; Goldfinger MH; Pearce RKB; Gentleman SM
J Parkinsons Dis; 2021; 11(4):1641-1650. PubMed ID: 34334423
[TBL] [Abstract][Full Text] [Related]
20. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Tsuboi Y; Uchikado H; Dickson DW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
